NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $185 | – | 223 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 223 | -99.7% | 0.00% | – |
| Q4 2022 | $37 | -99.9% | 72,967 | +28.2% | 0.00% | – |
| Q3 2022 | $36,000 | -59.1% | 56,932 | -33.4% | 0.00% | – |
| Q2 2022 | $88,000 | +69.2% | 85,512 | +210.0% | 0.00% | – |
| Q1 2022 | $52,000 | -93.8% | 27,585 | -84.3% | 0.00% | – |
| Q4 2021 | $845,000 | +22.8% | 175,209 | +84.4% | 0.00% | – |
| Q3 2021 | $688,000 | +355.6% | 95,035 | +484.2% | 0.00% | – |
| Q2 2021 | $151,000 | +0.7% | 16,267 | +33.9% | 0.00% | – |
| Q1 2021 | $150,000 | -26.8% | 12,145 | -16.4% | 0.00% | – |
| Q4 2020 | $205,000 | +42.4% | 14,519 | +18.9% | 0.00% | – |
| Q3 2020 | $144,000 | -16.8% | 12,209 | +17.5% | 0.00% | – |
| Q2 2020 | $173,000 | +3360.0% | 10,392 | +2498.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |